scholarly journals Evaluation of Reduced Port Laparoscopic Distal Gastrectomy Performed by a Novice Surgeon

2021 ◽  
Vol 21 (2) ◽  
pp. 179
Author(s):  
Dong Jin Park ◽  
Eun Ji Lee ◽  
Gyu Youl Kim
2017 ◽  
Vol 25 (1) ◽  
pp. 246-246 ◽  
Author(s):  
Tian Lin ◽  
Ting-yu Mou ◽  
Yan-feng Hu ◽  
Hao Liu ◽  
Tuan-jie Li ◽  
...  

2012 ◽  
Vol 29 (3) ◽  
pp. 261-268 ◽  
Author(s):  
Chikara Kunisaki ◽  
Hidetaka A. Ono ◽  
Takashi Oshima ◽  
Hirochika Makino ◽  
Hirotoshi Akiyama ◽  
...  

2021 ◽  
Vol 11 (1) ◽  
Author(s):  
Sung Eun Oh ◽  
Jeong Eun Seo ◽  
Ji Yeong An ◽  
Min-Gew Choi ◽  
Tae Sung Sohn ◽  
...  

AbstractThis phase II clinical trial was performed to determine whether reduced-port laparoscopic surgery with complete D2 lymph node (LN) dissection for gastric cancer is a safe and feasible surgical technique. The prospectively enrolled 65 gastric cancer patients underwent reduced-port surgery (i.e., triple-incision totally laparoscopic distal gastrectomy [Duet TLDG] with D2 lymphadenectomy). Compliance rate was the primary outcome, which was defined as cases in which there was no more than one missing LN station during D2 LN dissection. The secondary outcomes were the numbers of dissected and retrieved LNs in each station and other short-term surgical outcomes and postoperative course. The compliance rate was 58.5%. The total number of retrieved LNs was 41 (range: 14–83 LNs). The most common station missing from LN retrieval was station no. 5 (35/65; 53.8%), followed by station no. 1 (24/65; 36.9%). The overall postoperative complication rate was 20.0% (13/65). One patient underwent surgical treatment for postoperative complications. There was no instances of mortality. Duet TLDG is an oncologically and technically safe surgical method of gastrectomy and D2 lymphadenectomy.


PLoS ONE ◽  
2021 ◽  
Vol 16 (8) ◽  
pp. e0255855
Author(s):  
Dong Yeon Kang ◽  
Ho Goon Kim ◽  
Dong Yi Kim

Background Reduced-port laparoscopic gastrectomy is currently widely performed for patients with gastric cancer. However, its safety in obese patients has not yet been verified. This is the first study on reduced-port laparoscopic distal gastrectomy (RpLDG) in obese patients with gastric cancer. This study aimed to evaluate the short-term surgical outcomes and investigate the feasibility and safety of RpLDG in obese patients with gastric carcinoma. Material and methods A total of 271 gastric cancer patients who underwent RpLDG at our institution were divided into two groups: non-obese [body mass index (BMI) <30 kg/m2, n = 251; NOG] and obese (BMI ≥30 kg/m2, n = 20; OG). The mean age of the enrolled patients was 64.8 ± 11.4 years, with 72.0% being men and 28.0% women. Operative details and short-term surgical outcomes, including hospital course and postoperative complications, were compared by retrospectively reviewing the medical records. Results No significant difference in operation time was found between the NOG and OG (205.9 ± 40.0 vs. 211.3 ± 37.3 minutes, P = 0.563). Other operative outcomes in the OG, including estimated blood loss (54.1 ± 86.1 vs. 54.0 ± 39.0 mL, P = 0.995) and retrieved lymph nodes (36.2 ± 16.4 vs. 35.5 ± 18.2, P = 0.875), were not inferior to those in the NOG. There were also no statistical differences in short-term surgical outcomes, including the incidence of surgical complications (13.9% vs. 10.0%, P = 1). Conclusion RpLDG can be performed safely in obese gastric cancer patients by an experienced surgeon. It should be considered a feasible alternative to conventional port distal gastrectomy.


2003 ◽  
Vol 52 (4) ◽  
pp. 717-725
Author(s):  
Yoshibumi NIITSUMA ◽  
Tsuneo KAWASAKI ◽  
Hajime TSUKUI ◽  
Yoshinobu TAKAHASHI ◽  
Masamitsu MAEDA ◽  
...  

In Vivo ◽  
2019 ◽  
Vol 33 (6) ◽  
pp. 1993-1999
Author(s):  
KEITA KATSURAHARA ◽  
TOSHIYUKI KOSUGA ◽  
TAKESHI KUBOTA ◽  
ATSUSHI SHIOZAKI ◽  
KAZUMA OKAMOTO ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document